Geron (GERN) exits Stem Cell Research to focus on Cancer Treatments
The decision was made to conserve cash and resources on development on its cancer drugs Read more…
The decision was made to conserve cash and resources on development on its cancer drugs Read more…
Good morning! Here’s what you … might need to know to start the day … Read more…
End of Day, Cause and Effect … Read more…
A research network led by a Mayo Clinic physician found that stem cells obtained from bone marrow delivered 2 to 3 weeks after a person has a heart attack did not improve heart function. Read more…
New GeneCards^® release includes gene expression markers for ACTCellerate^TM cell lines Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
Setting the course for FY12 Read more…
Good morning! Here’s what you … might need to know to start the day … Read more…

Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.
